This study demonstrates an association between elevated pre-chemotherapy peripheral blood biomarkers of aging (IL-6 and D-dimer) and reduced RDI in women with stage I–III breast cancer receiving neoadjuvant or adjuvant chemotherapy. The gene discussed is IL6; the disease is breast cancer.